GCG and liver disorder: Furthermore, taking into consideration the beneficial impact of GLP-1 RAs on MASLD, it would be of strong interest to assess their efficacy on ALD and, more importantly, on patients whose liver disease has both an alcohol and a metabolic background (MetALD) [44].